First Capital Advisors »

Alnylam Pharmaceuticals shares owned by First Capital Advisors

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by First Capital Advisors from 13F filings

Historical chart of First Capital Advisors investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by First Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by First Capital Advisors

Quarter filed Position value Share count Share price at filing
2023-06-30 $80k 423 189.94

More positions owned by First Capital Advisors

Strategy Day Hagan Ned (SSUS)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Spdr Gold Tr Gold Shs (GLD)
J P Morgan Exchange Traded F Jpmorgan Diver (JPUS)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Legg Mason Etf Invt Franklin Intl Lw (LVHI)
Innovator Etfs Tr Us Eqty Pwr Buf (PMAR)
Invesco Exchange Traded Fd T S&p 500 Garp Etf (SPGP)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Microsoft Corporation (MSFT)
Ishares Tr Mbs Etf (MBB)
Goldman Sachs Etf Tr Activebeta Eme (GEM)

View all positions for First Capital Advisors

Top funds holding Alnylam Pharmaceuticals

Capital World Investors
FMR
Vanguard Group
BlackRock
Capital Research Global Investors
Wellington Management Company
Baillie Gifford & Co
Capital Research and Management Company - Division 3
Dodge & Cox
State Street Corporation
T. Rowe Price Associates
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
American Century Companies

View all funds holding Alnylam Pharmaceuticals